Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 32% ± 16% | |
peripheral blood | 16 studies | 27% ± 9% | |
brain | 6 studies | 28% ± 6% | |
uterus | 4 studies | 23% ± 8% | |
kidney | 4 studies | 23% ± 1% | |
breast | 4 studies | 21% ± 1% | |
intestine | 4 studies | 21% ± 7% | |
adipose | 3 studies | 24% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 22148.95 | 1445 / 1445 | 100% | 122.29 | 183 / 183 |
lung | 100% | 30202.75 | 578 / 578 | 99% | 150.15 | 1149 / 1155 |
kidney | 100% | 20459.72 | 89 / 89 | 99% | 94.77 | 895 / 901 |
thymus | 100% | 17667.04 | 653 / 653 | 99% | 112.11 | 598 / 605 |
intestine | 100% | 17035.29 | 966 / 966 | 98% | 94.17 | 519 / 527 |
breast | 100% | 24757.34 | 459 / 459 | 98% | 121.43 | 1097 / 1118 |
uterus | 100% | 18467.99 | 170 / 170 | 98% | 126.69 | 450 / 459 |
stomach | 100% | 23814.67 | 359 / 359 | 98% | 90.61 | 280 / 286 |
prostate | 100% | 14410.87 | 245 / 245 | 97% | 61.62 | 488 / 502 |
ovary | 100% | 20034.88 | 180 / 180 | 97% | 74.45 | 417 / 430 |
skin | 98% | 17356.65 | 1769 / 1809 | 99% | 105.99 | 466 / 472 |
brain | 96% | 7684.84 | 2545 / 2642 | 100% | 88.00 | 703 / 705 |
pancreas | 96% | 6711.77 | 315 / 328 | 99% | 160.44 | 176 / 178 |
bladder | 100% | 17946.00 | 21 / 21 | 92% | 85.52 | 464 / 504 |
adrenal gland | 100% | 23554.05 | 258 / 258 | 91% | 51.66 | 210 / 230 |
liver | 30% | 1463.86 | 67 / 226 | 74% | 40.89 | 301 / 406 |
adipose | 100% | 27854.07 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 23440.38 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 9780.04 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.94 | 1 / 1 |
muscle | 99% | 10172.30 | 794 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 8787.40 | 849 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 123.71 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 90% | 48.18 | 72 / 80 |
peripheral blood | 70% | 4670.14 | 649 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 45% | 18.50 | 13 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042542 | Biological process | response to hydrogen peroxide |
GO_0051493 | Biological process | regulation of cytoskeleton organization |
GO_2001247 | Biological process | positive regulation of phosphatidylcholine biosynthetic process |
GO_0016540 | Biological process | protein autoprocessing |
GO_0010666 | Biological process | positive regulation of cardiac muscle cell apoptotic process |
GO_0007565 | Biological process | female pregnancy |
GO_0035458 | Biological process | cellular response to interferon-beta |
GO_1901741 | Biological process | positive regulation of myoblast fusion |
GO_0001666 | Biological process | response to hypoxia |
GO_0006508 | Biological process | proteolysis |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0009612 | Biological process | response to mechanical stimulus |
GO_0001824 | Biological process | blastocyst development |
GO_0051603 | Biological process | proteolysis involved in protein catabolic process |
GO_0007520 | Biological process | myoblast fusion |
GO_0032675 | Biological process | regulation of interleukin-6 production |
GO_0048266 | Biological process | behavioral response to pain |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0005764 | Cellular component | lysosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0097038 | Cellular component | perinuclear endoplasmic reticulum |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0030864 | Cellular component | cortical actin cytoskeleton |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005925 | Cellular component | focal adhesion |
GO_0030425 | Cellular component | dendrite |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0110158 | Cellular component | calpain complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0031143 | Cellular component | pseudopodium |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0004198 | Molecular function | calcium-dependent cysteine-type endopeptidase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0008234 | Molecular function | cysteine-type peptidase activity |
GO_0008092 | Molecular function | cytoskeletal protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CAPN2 |
Protein name | Calpain 2 Calpain-2 catalytic subunit (EC 3.4.22.53) (Calcium-activated neutral proteinase 2) (CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain) (M-calpain) |
Synonyms | CANPL2 |
Description | FUNCTION: Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction. Proteolytically cleaves MYOC at 'Arg-226' . Proteolytically cleaves CPEB3 following neuronal stimulation which abolishes CPEB3 translational repressor activity, leading to translation of CPEB3 target mRNAs (By similarity). . |
Accessions | C9JWY7 ENST00000434648.5 ENST00000295006.6 [P17655-1] P17655 ENST00000433674.6 [P17655-2] |